Cellzome Reels in $5M German Tech Development Grant | GenomeWeb
NEW YORK (GenomeWeb News) – Cellzome will use a €3.85 million ($5 million) grant it has won from the German government as part of a high-tech funding program to expand its KinoBeads technology application.
The company plans to use the funds specifically to develop the KinoBeads platform for use in epigenetic target classes and to optimize it for diagnostic and translational medicine studies that would allow doctors to monitor target-drug interactions directly in patient material.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.